• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

混合异种嵌合体与耐受性III. 诱导对同时进行的胰岛异种移植产生供体特异性移植耐受性的非致死性方法。

Mixed xenogeneic chimerism and tolerance III. A nonlethal approach to induce donor-specific transplantation tolerance to simultaneous islet xenografts.

作者信息

Li H, Abou el-Ezz A Y, Gambrell B E, Ildstad S T

机构信息

Department of Surgery, University of Pittsburgh, Pennsylvania 15261, USA.

出版信息

Transplantation. 1995 Jul 15;60(1):59-65.

PMID:7624944
Abstract

Previously, we reported that transplantation of rat bone marrow into lethally irradiated (950 rads) mouse recipients results in stable xenogeneic (rat-->mouse) chimerism and confers donor-specific transplantation tolerance for subsequent or simultaneous islet xenografts. For potential clinical application of chimerism to induce tolerance, it would be important to avoid the morbidity and mortality associated with lethal conditioning. Recently, we established a model to achieve durable multilineage xenogeneic chimerism using a nonlethal cytoreductive approach. We report here for the first time that donor-specific rat islet xenografts placed coincident with the bone marrow transplant are permanently accepted by nonlethally conditioned recipients. All recipients conditioned with 700 cGy of total body irradiation and transplanted with 40 x 10(6) F344 rat bone marrow cells repopulated as mixed donor/host chimeras. The chimeras exhibited permanent acceptance of donor islet xenografts, since donor-specific F344 (Rt1A1) rat islet xenografts were significantly prolonged (median survival time > 110 days), while MHC-disparate third-party WF (Rt1Au) rat islets were prolonged but rejected (median survival time = 33.2 days). The islets were functional to maintain normoglycemia and regulated in function to respond to an intraperitoneal glucose challenge. These data suggest that tolerance to donor-specific islet xenografts placed coincident with bone marrow transplantation can be achieved after nonlethal conditioning.

摘要

此前,我们报道将大鼠骨髓移植到接受致死剂量照射(950拉德)的小鼠受体中,可导致稳定的异种(大鼠→小鼠)嵌合现象,并赋予对随后或同时进行的胰岛异种移植的供体特异性移植耐受性。对于嵌合现象在诱导耐受性方面的潜在临床应用而言,避免与致死性预处理相关的发病率和死亡率至关重要。最近,我们建立了一种使用非致死性细胞减灭方法实现持久多谱系异种嵌合的模型。我们在此首次报道,与骨髓移植同时植入的供体特异性大鼠胰岛异种移植物被非致死性预处理的受体永久接受。所有接受700厘戈瑞全身照射并移植40×10⁶个F344大鼠骨髓细胞的受体均重新填充为混合供体/宿主嵌合体。这些嵌合体对供体胰岛异种移植物表现出永久接受,因为供体特异性F344(Rt1A1)大鼠胰岛异种移植物的存活时间显著延长(中位存活时间>110天),而MHC不匹配的第三方WF(Rt1Au)大鼠胰岛虽存活时间延长但最终被排斥(中位存活时间=33.2天)。这些胰岛具有维持正常血糖水平的功能,并且其功能可调节以响应腹腔内葡萄糖刺激。这些数据表明,在非致死性预处理后,可以实现对与骨髓移植同时植入的供体特异性胰岛异种移植物的耐受性。

相似文献

1
Mixed xenogeneic chimerism and tolerance III. A nonlethal approach to induce donor-specific transplantation tolerance to simultaneous islet xenografts.混合异种嵌合体与耐受性III. 诱导对同时进行的胰岛异种移植产生供体特异性移植耐受性的非致死性方法。
Transplantation. 1995 Jul 15;60(1):59-65.
2
Mixed xenogeneic chimerism (mouse+rat-->mouse) to induce donor-specific tolerance to sequential or simultaneous islet xenografts.混合异种嵌合体(小鼠+大鼠→小鼠)以诱导对序贯或同时进行的胰岛异种移植的供体特异性耐受。
Transplantation. 1994 Feb 27;57(4):592-8.
3
Anti-mouse CD154 antibody treatment facilitates generation of mixed xenogeneic rat hematopoietic chimerism, prevents wasting disease and prolongs xenograft survival in mice.抗小鼠CD154抗体治疗有助于在小鼠中产生混合异种大鼠造血嵌合体,预防消瘦病并延长异种移植物的存活时间。
Xenotransplantation. 2006 May;13(3):224-32. doi: 10.1111/j.1399-3089.2006.00290.x.
4
Nonlethal conditioning for the induction of allogeneic chimerism and tolerance to islet allografts.用于诱导同种异体嵌合体形成及对胰岛同种异体移植耐受的非致死性预处理。
Transplantation. 2003 Apr 15;75(7):966-70. doi: 10.1097/01.TP.0000058516.74246.71.
5
A nonlethal conditioning approach to achieve durable multilineage mixed chimerism and tolerance across major, minor, and hematopoietic histocompatibility barriers.一种非致死性预处理方法,用于跨越主要、次要和造血组织相容性屏障实现持久的多谱系混合嵌合和耐受。
J Immunol. 1995 Nov 1;155(9):4179-88.
6
Mixed allogeneic chimerism in the rat. Donor-specific transplantation tolerance without chronic rejection for primarily vascularized cardiac allografts.大鼠中的混合异基因嵌合体。主要血管化心脏同种异体移植物的供体特异性移植耐受且无慢性排斥反应。
Transplantation. 1995 Nov 15;60(9):971-80.
7
Long-term survival of xenogeneic heart grafts achieved by costimulatory blockade and transient mixed chimerism.通过共刺激阻断和短暂混合嵌合实现异种心脏移植的长期存活。
Transplantation. 2006 Jul 27;82(2):275-81. doi: 10.1097/01.tp.0000226221.53161.10.
8
Mixed allogeneic chimerism achieved by lethal and nonlethal conditioning approaches induces donor-specific tolerance to simultaneous islet allografts.通过致死性和非致死性预处理方法实现的混合同种异体嵌合体可诱导对同时进行的胰岛同种异体移植的供体特异性耐受。
Transplantation. 1995 Sep 27;60(6):523-9. doi: 10.1097/00007890-199509270-00001.
9
Tacrolimus-based partial conditioning produces stable mixed lymphohematopoietic chimerism and tolerance for cardiac allografts.基于他克莫司的部分预处理可产生稳定的混合淋巴细胞造血嵌合体并诱导对心脏同种异体移植的耐受。
Circulation. 1998 Nov 10;98(19 Suppl):II163-8; discussion II168-9.
10
Durable mixed allogeneic chimerism and tolerance by a nonlethal radiation-based cytoreductive approach.通过基于非致死性辐射的细胞减灭方法实现持久的混合异体嵌合和耐受。
J Immunol. 1996 Oct 1;157(7):2820-9.

引用本文的文献

1
Past, present, and future prospects for inducing donor-specific transplantation tolerance for composite tissue allotransplantation.诱导复合组织同种异体移植供体特异性移植耐受的过去、现在和未来前景。
Semin Plast Surg. 2007 Nov;21(4):213-25. doi: 10.1055/s-2007-991191.